四川路橋(600039.SH):境外發行GDR並在瑞交所上市獲蜀道集團批覆
格隆匯2月1日丨四川路橋(600039.SH)公佈,公司於2023年2月1日收到控股股東蜀道投資集團有限責任公司(簡稱“蜀道集團”)出具的《蜀道投資集團有限責任公司關於四川路橋建設集團股份有限公司發行全球存託憑證有關問題的批覆》(蜀道司發〔2023〕23號),就公司境外發行全球存託憑證並在瑞士證券交易所上市有關事項批覆如下:
一、同意公司發行不超過總股本10%、對應A股股份數量不超過622,633,677股的全球存託憑證(GDR)的總體方案及相關事項。
二、公司應依法履行相關程序,推進上述事宜的相關工作,期間涉及的重大事項,以及該事項完成後,應及時向蜀道集團報吿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.